S&P Futures
6,013.75 +26.75 (+0.45%) Dow Futures
44,667.00 +272.00 (+0.61%) Nasdaq Futures
20,963.50 +113.75 (+0.55%) Russell 2000 Futures
2,439.00 +25.40 (+1.05%) Crude Oil
70.55 -0.69 (-0.97%) Gold
2,670.10 -42.10 (-1.55%)
Kiniksa Pharmaceuticals International, plc (KNSA)
After hours:
| Previous Close | 21.09 |
| Open | 21.16 |
| Bid | 21.20 x 100 |
| Ask | 21.29 x 400 |
| Day's Range | 21.12 - 21.48 |
| 52 Week Range | 15.52 - 28.15 |
| Volume | |
| Avg. Volume | 363,414 |
| Market Cap | 1.536B |
| Beta (5Y Monthly) | 0.35 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.12 |
| Earnings Date | Oct 29, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 36.00 |
Insider MonkeyIs Kiniksa Pharmaceuticals (KNSA) Top Performing European Stock Heading into 2025?
We recently published a list of 10 Top Performing European Stocks Heading into 2025. In this article, we are going to take a look at where Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) stands against other top performing European stocks. As per Deloitte, inflation in the Eurozone slightly rebounded in October but was still quite low. The consumer […]
GlobeNewswireKiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference
LONDON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the 2024 Jefferies London Healthcare Conference on Tuesday, November 19, 2024 at 12:00 p.m. Greenwich Mean Time (7:00 a.m. Eastern Time). A live webcast of Kiniksa’s presentation will be accessible through the Investors section of the company’s website at www.kiniksa.com. A replay of the event will also be available on Kiniksa’
